Amadix win the 2018 South Summit startup contest
The Spanish biotechnology company Amadix has won the startup contest of the South Summit 2018 with its method of early detection of certain types of cancer with blood tests.
This recognition will allow Amadix to carry out a crowdfunding campaign in Seedrs, a leading equity crowdfunding platform, and will compete for a million dollars in funding in the Silicon Valley Startup World Cup.
Amadix is a biotechnology company, led by Dr. Rocio Arroyo, developing innovative diagnostic tools in oncology to improve the diagnosis of different types of cancer through a non-invasive test. The mission of the Company is to create value for shareholders by developing and commercializing innovative diagnostic tools that address unmet medical needs in the field of oncology, reaching patients and physicians all around the world, with benefits for the company, community and researchers.
Amadix has a pipeline of innovative tests in development, for early diagnosis in colon, lung, and pancreatic cancer.
#Healthcare biotech; #Castile & Leon